In an effort to enhance regulatory oversight, the Central government has amended the Drugs Rules of 1945.
This change expands the Centrally License Approving Authority's purview to include emerging technologies like stem cell and gene therapeutic products.
Related current affairs
- The high cost of India’s private health-care boom
- HUMERUS (cartoon)
- A healthy tax
- Vaccines and timely fair access
- RBSK 2.0 guidelines expanded to address childhood non-communicable diseases and obesity-related concerns
- Union Health Minister addresses 10th convocation of ILBS; highlights healthcare expansion and Ayushman Arogya Mandirs screening